CLASS II Device recall · Reported 7 Dec 2016 · FDA Enforcement Report

Bridge Occlusion Balloon recalled by Spectranetics

Spectranetics is recalling Bridge Occlusion Balloon, distributed nationwide in the US. The recall was initiated on 31 Oct 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesFMN16E11A; FMN16E18A; FMN16E25A; FMN16F01A; FMN16F08A; FMN16F15A FMN16F22A; FMN16G13A; FMN16G19A; FMN16G25A; FMN16H04A; FMN16H23A; FMN16J27A
Quantity recalled873 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0663-2017
FDA event ID
75617
Recalling firm
Spectranetics, Colorado Springs, CO
Classification
Class II
Status
Terminated
Recall initiated
31 Oct 2016
FDA classified
1 Dec 2016
Reported
7 Dec 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

31 Oct 2016Recall initiated by company
1 Dec 2016Classified by FDA+31 days
7 Dec 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Spectranetics Corporation announces a voluntary field action for the Turbo Elite Atherectomy Catheter, ELCA Coronary Atherectomy Catheter, and Bridge Occlusion Balloon due to potentially compromised integrity of the outer sterile packaging.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Bridge Occlusion Balloon. Model: 590-001 Temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage. Any use for procedures other than those indicated in the instructions is not recommended.

Where it was distributed

Worldwide Distribution - US (nationwide and PR) Internationally to Austria, Belgium, Cyprus, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, Australia, Bahrain, Brazil, Canada, Chile, Colombia, Dominican Republic, Israel, Japan, Kuwait, Taiwan, Thailand.

Nationwide Puerto Rico

Questions about this recall

Is Bridge Occlusion Balloon recalled?

Yes. Spectranetics recalled Bridge Occlusion Balloon on 31 Oct 2016. The recall is Class II and its status is Terminated. Recall number Z-0663-2017.

Why was it recalled?

Spectranetics Corporation announces a voluntary field action for the Turbo Elite Atherectomy Catheter, ELCA Coronary Atherectomy Catheter, and Bridge Occlusion Balloon due to potentially compromised integrity of the outer sterile packaging.

Which lots are affected?

FMN16E11A; FMN16E18A; FMN16E25A; FMN16F01A; FMN16F08A; FMN16F15A FMN16F22A; FMN16G13A; FMN16G19A; FMN16G25A; FMN16H04A; FMN16H23A; FMN16J27A

Where was it sold?

Worldwide Distribution - US (nationwide and PR) Internationally to Austria, Belgium, Cyprus, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, Australia, Bahrain, Brazil, Canada, Chile, Colombia, Dominican Republic, Israel, Japan, Kuwait, Taiwan, Thailand.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Spectranetics

All 12

Other Heart & Vascular Devices recalls

All 6,190